Theriva Biologics
TOVX
TOVX
53 hedge funds and large institutions have $20.6M invested in Theriva Biologics in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
28% less funds holding
Funds holding: 74 → 53 (-21)
78% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 27
Holders
53
Holding in Top 10
1
Calls
$5.91M
Puts
–
Top Buyers
| 1 | +$629K | |
| 2 | +$521K | |
| 3 | +$273K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$207K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$194K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$715K | |
| 3 | -$532K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$466K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$228K |